Form 4: HealthEquity Director Adrian Dillon Reports Acquisition of 2,543 Shares
SEC Form 4
Director Adrian Dillon reported acquiring 2,543 shares of HealthEquity, Inc. common stock on July 5, 2024.
Summary
- On July 5, 2024, Adrian Dillon, a director of HealthEquity, Inc., acquired 2,543 shares of common stock.
- The shares were acquired at a price of $0.
- Following the transaction, Dillon directly owns 57,515 shares of HealthEquity, Inc.
- Dillon also holds options to purchase shares of common stock at various exercise prices and expiration dates.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing a director's stock acquisition. It doesn't inherently convey strong positive or negative sentiment, but insider buying is often viewed as a mildly positive signal.
Positives
- The director's acquisition of shares could be interpreted as a positive signal about their confidence in the company's future prospects.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. Investors often monitor these filings to gauge sentiment and potential future performance.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 02/05/2024 | Power of Attorney given by Mr. Dillon was previously filed with the U.S. Securities & Exchange Commission. |
| 07/05/2024 | Date of transaction: Adrian Dillon acquired 2,543 shares of HealthEquity, Inc. common stock. |
| 07/05/2025 | Restricted stock units vest in full on the earlier of this date or the date of the issuer's next annual stockholder meeting. |
| 07/09/2024 | Date of signature of the report. |
| 09/01/2026 | Expiration date for stock options to purchase 7,632 shares at $32.5. |
| 02/01/2027 | Expiration date for stock options to purchase 4,837 shares at $46.4. |
| 02/01/2028 | Expiration date for stock options to purchase 4,339 shares at $50.41. |
| 02/01/2029 | Expiration date for stock options to purchase 3,626 shares at $63.64. |
| 02/01/2030 | Expiration date for stock options to purchase 4,012 shares at $66.06. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.